Skip to main content
. 2023 Jun 16;14:20417314231175364. doi: 10.1177/20417314231175364

Table 3.

Histone modification and mechanism during the osteogenic differentiation of MSCs.

Histone modifier Modification MSC type Target genes Mechanism Ref.
EHMT1 Methylation BMSC RUNX2 EHMT1 upregulated the H3K9me2 levels at the promoter of RUNX2, resulting in the repression of osteogenesis. Huang et al. 102
ASH1L Methylation BMSC OSX
RUNX2
ASH1L-mediated H3K4me3 occurred at the promoter regions of OSX and RUNX2, ultimately promoting osteogenic differentiation. Yin et al. 103
PRMT3 Methylation MSC miR-3648 PRMT3 activated the expression of miR-3648 by enhancing H4R3me2a levels at its promoter region, resulting in the promotion of osteogenic differentiation. Min et al. 104
CARM1 Methylation BMSC OCT4
SOX2
ANOG
CARM1 was enriched on OCT4, SOX2, and NANOG promoter sites by enhancing di-methylation of H3R17 of these genes, resulting in the promotion of osteogenesis. Jo et al. 105
LSD1 Demethylation BMSC RUNX2
OCN
LSD1 catalyzed the demethylation of di- and mono-methylation of H3K4 at RUNX2 and OCN promoter regions, resulting in the repression of osteogenic differentiation. Lv et al. 106
LSD1 Demethylation ADSC BMP2
SMAD4
Silencing of LSD1 promoted the osteoblastic potential by stimulating BMP2/SMAD4 signaling pathway. Ma et al. 107
KDM1A Demethylation BMSC circ_AFF4
FNDC5
KDM1A promoted circ_AFF4 and FNDC5 expression via reducing H3K9me3, thus inducing circ_AFF4 and FNDC5 expression and osteogenesis. Liu et al. 108
GCN5 Acetylation ADSC NF-κB GCN5 repressed NF-κB-dependent transcription and inhibited the NF-κB signaling pathway, thus promoting osteogenic differentiation Zhang et al. 109
HBO1 Acetylation ADSC 14-3-3β HBO1 suppressed the expression of 14-3-3β via increasing its acK49/51 acetylation, resulting in the promotion of osteogenic differentiation. Frontini-López et al. 110
SIRT6 Deacetylation MSC BMP2
BMP4
BMPR1A
BMPR1B
SIRT6 promoted osteogenic differentiation through BMP signaling pathway. Zhang et al. 111
HDAC9 Deacetylation BMSC pERK1/2 Silencing of HDAC9 reduced the expression level of pERK1/2 and inhibited osteogenic differentiation. Wang et al. 112